Literature DB >> 10371274

5'-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients.

S M Johnson1, S Patel, F E Bruckner, D A Collins.   

Abstract

OBJECTIVES: To evaluate measurements of serum and synovial fluid 5'-nucleotidase (5'N) activity as a marker of general and local inflammation in arthritis, and to resolve a contradiction in the literature as to whether or not the activity of 5'N in the synovial fluids of rheumatoid arthritis (RA) patients is raised in comparison with that in the synovial fluids of other arthritis patients.
METHODS: Assays for 5'N were carried out in the presence of inhibitors of other phosphatases, AMP deaminase and of 5'N itself.
RESULTS: The 5'N activity in the synovial fluid of RA patients was both significantly higher (mean 1.7-fold) and had a greater variance than that in the synovial fluids of other arthritis patients, and the contradiction in the literature was resolved. There was a strong correlation between the 5'N activity in the sera of RA patients and their erythrocyte sedimentation rate. There was no significant correlation between the 5'N in the serum and synovial fluid for the RA patients, in marked contrast to the strong correlation between the two 5'N activities shown by the osteoarthritis patients. The 5'N activity was greater in the synovial fluid than in the serum for virtually all the patients, showing that it was being made locally.
CONCLUSIONS: The 5'N activity in the serum (which came mostly from the liver) could be used as a marker of general inflammation, whereas the 5'N in the synovial fluid was mostly produced locally, and could be used as a marker of joint inflammation, particularly for the RA patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371274     DOI: 10.1093/rheumatology/38.5.391

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.

Authors:  Ahmed S Ibrahim; Mamdouh M El-Shishtawy; Wenbo Zhang; Ruth B Caldwell; Gregory I Liou
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

3.  Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.

Authors:  Gregory I Liou
Journal:  World J Diabetes       Date:  2010-03-15

4.  The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis.

Authors:  Sheena M Johnson
Journal:  Immunology       Date:  2007-08-04       Impact factor: 7.397

Review 5.  Generation and Function of Non-cell-bound CD73 in Inflammation.

Authors:  Enja Schneider; Anne Rissiek; Riekje Winzer; Berta Puig; Björn Rissiek; Friedrich Haag; Hans-Willi Mittrücker; Tim Magnus; Eva Tolosa
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.